Tech Company Financing Transactions
Excaliard Pharmaceuticals Funding Round
Alta Partners, RiverVest Venture Partners and private investors participated in a $2.5 million funding round for Excaliard Pharmaceuticals. The funding round closed on 3/31/2010.
Transaction Overview
Company Name
Announced On
3/31/2010
Transaction Type
Venture Equity
Amount
$2,500,000
Round
Undisclosed
Investors
Alta Partners (Farah Champsi)
RiverVest Venture Partners (Gordon Foulkes)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
2141 Palomar Airport Road 300
Carlsbad, CA 92011
USA
Carlsbad, CA 92011
USA
Phone
Website
Email Address
Overview
The company develops therapeutics for the treatment of scarring and fibrotic disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
Ian Wisenberg
Chief Medical Officer
Gary Gentzkow
Chief Scientific Officer
Nicholas Dean
President
Gordon Foulkes
VP - Operations
Jeff Jensen
VP - Regulatory Affairs
Elizabeth Gordon
Browse more venture capital transactions:
Prev: 3/31/2010: Adhezion Biomedical venture capital transaction
Next: 3/31/2010: AdventureLink Travel venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record tech company VC transactions. VC transactions reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs